In another study, up-regulation of HIF-1α expression was also observed in patients with ovarian cancer, and HIF-1α overexpression in ovarian tumor tissues not only accelerated the development and progression of cancer, but also induced the formation of drug resistance, which in turn led to poor treatment outcomes [13]. Here, HIF1A is linked to ovarian carcinoma.